Clinical Trial Update: A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of JNJ-95566692 in participants with non-Hodgkin lymphoid malignancies, with the study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• JNJ-95566692

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Lymphoma, Non-Hodgkin | Phase 1 | Status: RECRUITING